Cancer stem cell metabolism: target for cancer therapy

키워드

참고문헌 (80)

1. Pavlova NN, "The Emerging Hallmarks of Cancer Metabolism", Cell Metab, 23, pp.27~47 (2016)[DOI]
2. Kreso A, "Evolution of the cancer stem cell model", Cell Stem Cell, 14, pp.275~291 (2014)[DOI]
3. Clevers H, "The cancer stem cell: premises, promises and challenges", Nat Med, 17, pp.313~319 (2011)[DOI]
4. Facucho-Oliveira JM, "The relationship between pluripotency and mitochondrial DNA proliferation during early embryo development and embryonic stem cell differentiation", Stem Cell Rev, 5, pp.140~158 (2009)[DOI]
5. Mohyeldin A, "Oxygen in stem cell biology: a critical component of the stem cell niche", Cell Stem Cell, 7, pp.150~161 (2010)[DOI]
6. Zou ZW, "LncRNA ANRIL is up-regulated in nasopharyngeal carcinoma and promotes the cancer progression via increasing proliferation, reprograming cell glucose metabolism and inducing sidepopulation stem-like cancer cells", Oncotarget, 7, pp.61741~61754 (2016)
7. Cairns RA, "Regulation of cancer cell metabolism", Nat Rev Cancer, 11, pp.85~95 (2011)[DOI]
8. Kroemer G, "Tumor cell metabolism: cancer's Achilles' heel", Cancer Cell, 13, pp.472~482 (2008)[DOI]
9. Dang CV, "Links between metabolism and cancer", Genes Dev, 26, pp.877~890 (2012)[DOI]
10. Cantor JR, "Cancer cell metabolism: one hallmark, many faces", Cancer Discov, 2, pp.881~898 (2012)[DOI]
11. Eales KL, "Hypoxia and metabolic adaptation of cancer cells", Oncogenesis, 5, pp.e190~ (2016)[DOI]
12. Majewski N, "Hexokinase-mitochondria interaction mediated by Akt is required to inhibit apoptosis in the presence or absence of Bax and Bak", Mol Cell, 16, pp.819~830 (2004)[DOI]
13. Lu C, "Metabolic regulation of epigenetics", Cell Metab, 16, pp.9~17 (2012)[DOI]
14. Dang L, "Cancer-associated IDH1 mutations produce 2-hydroxyglutarate", Nature, 465, pp.966~ (2010)
15. Lu C, "IDH mutation impairs histone demethylation and results in a block to cell differentiation", Nature, 483, pp.474~478 (2012)[DOI]
16. Hirschhaeuser F, "Lactate: a metabolic key player in cancer", Cancer Res, 71, pp.6921~6925 (2011)[DOI]
17. Pattabiraman DR, "Tackling the cancer stem cells - what challenges do they pose?", Nat Rev Drug Discov, 13, pp.497~512 (2014)[DOI]
18. Nguyen LV, "Cancer stem cells: an evolving concept", Nat Rev Cancer, 12, pp.133~143 (2012)[DOI]
19. Cheung TH, "Molecular regulation of stem cell quiescence", Nat Rev Mol Cell Biol, 14, pp.329~340 (2013)[DOI]
20. Lapidot T, "A cell initiating human acute myeloid leukaemia after transplantation into SCID mice", Nature, 367, pp.645~648 (1994)[DOI]
21. Al-Hajj M, "Prospective identification of tumorigenic breast cancer cells", Proc Natl Acad Sci U S A, 100, pp.3983~3988 (2003)[DOI]
22. Ginestier C, "ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome", Cell Stem Cell, 1, pp.555~567 (2007)[DOI]
23. Hemmati HD, "Cancerous stem cells can arise from pediatric brain tumors", Proc Natl Acad Sci U S A, 100, pp.15178~15183 (2003)[DOI]
24. Singh SK, "Identification of a cancer stem cell in human brain tumors", Cancer Res, 63, pp.5821~5828 (2003)
25. Ricci-Vitiani L, "Identification and expansion of human colon-cancerinitiating cells", Nature, 445, pp.111~115 (2007)[DOI]
26. Collins AT, "Prospective identification of tumorigenic prostate cancer stem cells", Cancer Res, 65, pp.10946~10951 (2005)[DOI]
27. Eramo A, "Identification and expansion of the tumorigenic lung cancer stem cell population", Cell Death Differ, 15, pp.504~514 (2008)[DOI]
28. Schatton T, "Identification of cells initiating human melanomas", Nature, 451, pp.345~349 (2008)[DOI]
29. Merlos-Suarez A, "The intestinal stem cell signature identifies colorectal cancer stem cells and predicts disease relapse", Cell Stem Cell, 8, pp.511~524 (2011)[DOI]
30. Hermann PC, "Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer", Cell Stem Cell, 1, pp.313~323 (2007)[DOI]
31. Ito K, "Metabolic requirements for the maintenance of self-renewing stem cells", Nat Rev Mol Cell Biol, 15, pp.243~256 (2014)[DOI]
32. Muz B, "The role of hypoxia in cancer progression, angiogenesis, metastasis and resistance to therapy", Hypoxia (Auckl), 3, pp.83~92 (2015)
33. Kleffel S, "Tumor dormancy and cancer stem cells: two sides of the same coin?", Adv Exp Med Biol, 734, pp.145~179 (2013)
34. Giancotti FG, "Mechanisms governing metastatic dormancy and reactivation", Cell, 155, pp.750~764 (2013)[DOI]
35. Folmes CD, "Metabolic plasticity in stem cell homeostasis and differentiation", Cell Stem Cell, 11, pp.596~606 (2012)[DOI]
36. Panopoulos AD, "The metabolome of induced pluripotent stem cells reveals metabolic changes occurring in somatic cell reprogramming", Cell Res, 22, pp.168~177 (2012)[DOI]
37. Liu PP, "Metabolic regulation of cancer cell side population by glucose through activation of the Akt pathway", Cell Death Differ, 21, pp.124~135 (2014)[DOI]
38. Zhou Y, "Metabolic alterations in highly tumorigenic glioblastoma cells: preference for hypoxia and high dependency on glycolysis", J Biol Chem, 286, pp.32843~32853 (2011)[DOI]
39. Ciavardelli D, "Breast cancer stem cells rely on fermentative glycolysis and are sensitive to 2-deoxyglucose treatment", Cell Death Dis, 5, pp.e1336~ (2014)[DOI]
40. Liao J, "Ovarian cancer spheroid cells with stem cell-like properties contribute to tumor generation, metastasis and chemotherapy resistance through hypoxia-resistant metabolism", PLoS One, 9, pp.e84941~ (2014)[DOI]
41. Emmink BL, "The secretome of colon cancer stem cells contains drugmetabolizing enzymes", J Proteomics, 91, pp.84~96 (2013)[DOI]
42. Tamada M, "Modulation of glucose metabolism by CD44 contributes to antioxidant status and drug resistance in cancer cells", Cancer Res, 72, pp.1438~1448 (2012)[DOI]
43. Janiszewska M, "Imp2 controls oxidative phosphorylation and is crucial for preserving glioblastoma cancer stem cells", Genes Dev, 26, pp.1926~1944 (2012)[DOI]
44. Lagadinou ED, "BCL-2 inhibition targets oxidative phosphorylation and selectively eradicates quiescent human leukemia stem cells", Cell Stem Cell, 12, pp.329~341 (2013)[DOI]
45. Sancho P, "MYC", PGC-1alpha Balance Determines the Metabolic Phenotype and Plasticity of Pancreatic Cancer Stem Cells, 2015, pp.22, 590~605
46. Viale A, "Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function", Nature, 514, pp.628~632 (2014)[DOI]
47. Tan Z, "The Role of PGC1alpha in Cancer Metabolism and its Therapeutic Implications", Mol Cancer Ther, 15, pp.774~782 (2016)[DOI]
48. LeBleu VS, "PGC-1alpha mediates mitochondrial biogenesis and oxidative phosphorylation in cancer cells to promote metastasis", Nat Cell Biol, 16, pp.992~ (2014)[DOI]
49. Peiris-Pages M, "Cancer stem cell metabolism", Breast Cancer Res, 18, pp.55~ (2016)[DOI]
50. Chen CL, "NANOG Metabolically Reprograms Tumor-Initiating Stem-like Cells through Tumorigenic Changes in Oxidative Phosphorylation and Fatty Acid Metabolism", Cell Metab, 23, pp.206~219 (2016)[DOI]
51. Vazquez F, "PGC1alpha expression defines a subset of human melanoma tumors with increased mitochondrial capacity and resistance to oxidative stress", Cancer Cell, 23, pp.287~301 (2013)[DOI]
52. Yajima T, "Resistance to cytotoxic chemotherapyinduced apoptosis in side population cells of human oral squamous cell carcinoma cell line Ho-1-N-1", Int J Oncol, 35, pp.273~280 (2009)
53. Zhang G, "Targeting mitochondrial biogenesis to overcome drug resistance to MAPK inhibitors", J Clin Invest, 126, pp.1834~1856 (2016)[DOI]
54. Lee KM, "MYC and MCL1 Cooperatively Promote Chemotherapy-Resistant Breast Cancer Stem Cells via Regulation of Mitochondrial Oxidative Phosphorylation", Cell Metab, 26, pp.633~647 (2017)[DOI]
55. Tan AS, "Mitochondrial genome acquisition restores respiratory function and tumorigenic potential of cancer cells without mitochondrial DNA", Cell Metab, 21, pp.81~94 (2015)[DOI]
56. Cluntun AA, "Glutamine Metabolism in Cancer: Understanding the Heterogeneity", Trends Cancer, 3, pp.169~180 (2017)[DOI]
57. Oburoglu L, "Glucose and glutamine metabolism regulate human hematopoietic stem cell lineage specification", Cell Stem Cell, 15, pp.169~184 (2014)[DOI]
58. Kim JH, "Effects of metformin on colorectal cancer stem cells depend on alterations in glutamine metabolism", Sci Rep, 8, pp.409~ (2018)[DOI]
59. Mancini R, "Metabolic features of cancer stem cells: the emerging role of lipid metabolism", Oncogene, 37, pp.2367~2378 (2018)[DOI]
60. Gupta VK, "Isolation of Lipid Raft Proteins from CD133+ Cancer Stem Cells", Methods Mol Biol, 1609, pp.25~31 (2017)
61. Babina IS, "A novel mechanism of regulating breast cancer cell migration via palmitoylation-dependent alterations in the lipid raft affiliation of CD44", Breast Cancer Res, 16, pp.R19~ (2014)[DOI]
62. Murai T, "Low cholesterol triggers membrane microdomain-dependent CD44 shedding and suppresses tumor cell migration", J Biol Chem, 286, pp.1999~2007 (2011)[DOI]
63. Tirinato L, "Lipid droplets: a new player in colorectal cancer stem cells unveiled by spectroscopic imaging", Stem Cells, 33, pp.35~44 (2015)[DOI]
64. Luo X, "Emerging roles of lipid metabolism in cancer metastasis", Mol Cancer, 16, pp.76~ (2017)
65. Li J, "Lipid Desaturation Is a Metabolic Marker and Therapeutic Target of Ovarian Cancer Stem Cells", Cell Stem Cell, 20, pp.303~314 (2017)[DOI]
66. Wang T, "JAK", STAT3-Regulated Fatty Acid beta-Oxidation Is Critical for Breast Cancer Stem Cell Self-Renewal and Chemoresistance, 2018, pp.27, 136~150
67. Ito K, "A PML-PPARdelta pathway for fatty acid oxidation regulates hematopoietic stem cell maintenance", Nat Med, 18, pp.1350~1358 (2012)[DOI]
68. Pascual G, "Targeting metastasis-initiating cells through the fatty acid receptor CD36", Nature, 541, pp.41~45 (2017)[DOI]
69. Vlashi E, "Metabolic state of glioma stem cells and nontumorigenic cells", Proc Natl Acad Sci U S A, 108, pp.16062~16067 (2011)[DOI]
70. Dong C, "Loss of FBP1 by Snail-mediated repression provides metabolic advantages in basal-like breast cancer", Cancer Cell, 23, pp.316~331 (2013)[DOI]
71. Vander Heiden MG, "Targeting cancer metabolism: a therapeutic window opens", Nat Rev Drug Discov, 10, pp.671~684 (2011)[DOI]
72. Semenza GL, "Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy", Trends Pharmacol Sci, 33, pp.207~214 (2012)[DOI]
73. Kim JW, "HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia", Cell Metab, 3, pp.177~185 (2006)[DOI]
74. Dupuy F, "PDK1-Dependent Metabolic Reprogramming Dictates Metastatic Potential in Breast Cancer", Cell Metab, 22, pp.577~589 (2015)[DOI]
75. Peng F, "Glycolysis gatekeeper PDK1 reprograms breast cancer stem cells under hypoxia", Oncogene, 37, pp.1062~1074 (2018)[DOI]
76. Xia P, "PI3K", Akt, Am J Cancer Res, pp.2015, 5[DOI]
77. Hirsch HA, "Metformin selectively targets cancer stem cells, and acts together with chemotherapy to block tumor growth and prolong remission", Cancer Res, 69, pp.7507~7511 (2009)[DOI]
78. Lamb R, "Antibiotics that target mitochondria effectively eradicate cancer stem cells, across multiple tumor types: treating cancer like an infectious disease", Oncotarget, 6, pp.4569~4584 (2015)
79. Chae YC, "Control of tumor bioenergetics and survival stress signaling by mitochondrial HSP90s", Cancer Cell, 22, pp.331~344 (2012)[DOI]
80. Chae YC, "Landscape of the mitochondrial Hsp90 metabolome in tumours", Nat Commun, 4, pp.2139~ (2013)[DOI]